PROF. DAVID RON, M.D.
Osteopathic Medicine at 1 Ave, New York, NY
License number
New York 190927-1
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
540 1St Ave, New York, NY 10016
Phone
(212) 263-7786
(212) 263-8951 (Fax)
(212) 982-5991
(212) 263-8951 (Fax)
(212) 982-5991
Personal information
See more information about DAVID RON at radaris.comName
Address
Phone
1 Washington Square Vlg APT 6D, New York, NY 10012
50 Guion Pl, New Rochelle, NY 10801
1 Washington Square Vlg, New York, NY 10012
15218 Union Tpke, Flushing, NY 11367
New York, NY
Organization information
See more information about DAVID RON at bizstanding.comDavid Ron MD
540 1 Ave, New York, NY 10016
Industry:
Internist
Phone:
(212) 263-7300 (Phone)
David Ron
Professional information
David Ron, New York NY
Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism
Work:
New York University
540 1St Ave, New York, NY 10016
540 1St Ave, New York, NY 10016
Education:
Technion Israel Institute Of Technology (1980)
Dr. David Ron, New York NY - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
540 1St Ave, New York 10016
(212) 263-7786 (Phone), (212) 263-8951 (Fax)
(212) 263-7786 (Phone), (212) 263-8951 (Fax)
Certifications:
Diabetes, Metabolism & Endocrinology, 1989, Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Technion-Israel Institute of Technology / Faculty of Medicine
Mount Sinai Hospital
Massachusetts General Hospital
Technion-Israel Institute of Technology / Faculty of Medicine
Mount Sinai Hospital
Massachusetts General Hospital
Restaurants Professional
Location:
Greater New York City Area
Industry:
Restaurants
Method Of Identifying Substances Useful For Promoting Resistance To Cell Stress
US Patent:
7306905, Dec 11, 2007
Filed:
May 17, 2002
Appl. No.:
10/150759
Inventors:
David Ron - New York NY, US
Heather P. Harding - Brooklyn NY, US
Heather P. Harding - Brooklyn NY, US
Assignee:
New York University - New York NY
International Classification:
C12Q 1/68, C12Q 1/00
US Classification:
435 6, 435 4, 435 29
Abstract:
The invention is directed to methods for identifying test substances useful for the prevention or treatment of diseases involving an oxidative stress. The methods involve screening assays, including high throughput screening techniques, in which the test substances are tested for their ability to promote resistance to oxidative stress by activating one or more points of the integrated stress response pathway, while not causing stress.
Method Of Screening Test Substances For Treating Or Preventing A Disease Mediated By Plasma Cells
US Patent:
7666587, Feb 23, 2010
Filed:
Apr 11, 2003
Appl. No.:
10/413538
Inventors:
David Ron - New York NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Assignee:
New York University - New York NY
International Classification:
C12Q 1/68
US Classification:
435 6, 435 4
Abstract:
The present invention relates to a method of screening a compound for potential effectiveness in treating or preventing a mammalian disease mediated by plasma cells or a mammalian disease caused by virus infection of mammalian cells. Compounds are tested for their ability to inhibit IRE1-mediated processing of untranslatable XBP-1 mRNA into translatable XBP-1 mRNA. Drugs that are useful in treating or preventing a mammalian disease mediated by plasma cells and a method for detecting XBP-1 activity in living cells are also described.
Methods Of Screening Test Compounds Using Gadd34L, An Eif2Alpha-Specific Phosphatase Subunit
US Patent:
2004014, Jul 22, 2004
Filed:
Aug 28, 2003
Appl. No.:
10/650482
Inventors:
David Ron - New York NY, US
Celine Jousse - Saint Genes Champanelle, FR
Celine Jousse - Saint Genes Champanelle, FR
International Classification:
C12Q001/68, G01N033/53, G01N033/567
US Classification:
435/006000, 435/007200
Abstract:
The invention is directed to methods and reagents for identifying test substances useful for the prevention or treatment of diseases involving an oxidative stress. The methods involve screening assays, including high throughput screening techniques, in which the test substances are tested for their ability to promote resistance to oxidative stress by inhibiting the activity of GADD34L, and thereby inhibiting the dephosphorylation of eIF2, while not causing stress.
Method Of Screening Test Substances For Treating Or Preventing A Disease Mediated By Plasma Cells
US Patent:
2010010, Apr 29, 2010
Filed:
Dec 30, 2009
Appl. No.:
12/649849
Inventors:
David Ron - New York NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Assignee:
NEW YORK UNIVERSITY - New York NY
International Classification:
C12Q 1/68, C07H 21/02
US Classification:
435 6, 536 231
Abstract:
The present invention relates to a method of screening a compound for potential effectiveness in treating or preventing a mammalian disease mediated by plasma cells or a mammalian disease caused by virus infection of mammalian cells. Compounds are tested for their ability to inhibit IRE1-mediated processing of untranslatable XBP-1 mRNA into translatable XBP-1 mRNA. Drugs that are useful in treating or preventing a mammalian disease mediated by plasma cells and a method for detecting XBP-1 activity in living cells are also described.
Osteopathic Medicine licenses in New York
CHRISTOPHER IROBUNDA, Osteopathic Medicine, 161 Fort Washington Ave 6 FLOOR CIVT, New York, NY 10032